Analysis

Clearpoint Neuro Inc. (CLPT) Stock Analysis

Clearpoint Neuro Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CLPT.

websiteCLPT/analysis/CLPT

Clearpoint Neuro Inc.

Clearpoint Neuro Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CLPT.

Stock profile

Ticker

CLPT

Asset type

Stock

Market cap

$532.9M

Sector

Health Technology

Industry

Medical Specialties

Currency

USD

Ticker listings

Clearpoint Neuro Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • CLPT primary listing

Latest Clearpoint Neuro Inc. news

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expand...

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Glob...

ClearPoint Neuro Reports First Quarter 2026 Results

Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (...

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem an...

SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise n...

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering pre...

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Exp...

SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise...

Research sections

Valuation

Review valuation context for Clearpoint Neuro Inc..

Future growth

Review future growth context for Clearpoint Neuro Inc..

Past performance

Review past performance context for Clearpoint Neuro Inc..

Financial health

Review financial health context for Clearpoint Neuro Inc..

Dividend

Review dividend context for Clearpoint Neuro Inc..

Management

Review management context for Clearpoint Neuro Inc..

Ownership

Review ownership context for Clearpoint Neuro Inc..

Other information

Review other information context for Clearpoint Neuro Inc..

Community

Review community context for Clearpoint Neuro Inc..